Title: Reduced Shigella Susceptibility to Ciprofloxacin<br/>Author: Jon Mark Hirshon<br/><a href='http://umem.org/profiles/faculty/96/'>[Click to email author]</a><hr/><p>
        The Centers for Disease Control and Prevention (CDC) just released an official health advisory through the Health Alert Network entitled: “CDC Recommendations for Diagnosing and Managing Shigella Strains with Possible Reduced Susceptibility to Ciprofloxacin”</p>
<p>
         </p>
<p>
        Concerning treatment, one key point is:</p>
<p>
        <strong>Do not routinely prescribe antibiotic therapy for <em>Shigella</em> infection. Instead, reserve antibiotic therapy</strong> <strong>for patients for whom it is clinically indicated or when public health officials advise treatment in an outbreak setting.</strong></p>
<p style="margin-left:18.75pt;">
        o   Shigellosis is generally a self-limited infection lasting 5-7 days.</p>
<p style="margin-left:18.75pt;">
        o   Unnecessary treatment with antibiotics promotes resistance.</p>
<p style="margin-left:18.75pt;">
        o   Treatment can shorten the duration of some illnesses, though typically only by 1-2 days</p>

                <div align='center'>
                <a href='http://www.umem.org/educational_pearls/3234/' target='_blank'><b>CLICK TO VIEW MORE IN-DEPTH INFORMATION</b></a><br/>
                (Must disable pop-up blocker to open new window)
                </div>
                <fieldset><legend>References</legend>

                <p>
        https://emergency.cdc.gov/han/han00401.asp</p>
</fieldset>